Skip to main content

Nuss John's Form 4 filing

Ventyx Biosciences, Inc. (VTYX) · filed Dec 19, 2024

Accession no.
0001415889-24-029920
Filed
Dec 19, 2024
Trade date
Dec 17-19, 2024
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $29.7K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Nuss JohnCIK 0001874108Officer (CHIEF SCIENTIFIC OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 17, 2024Common StockMOption exerciseAcquired+34,930$0.00F1$0498,862Direct
Dec 19, 2024Common StockSSaleDisposed−13,161$2.26F3−$29,743.86485,701Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 17, 2024Common StockMOption exerciseDisposed−34,930$0.00$034,930Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Ventyx Biosciences, Inc. common stock.

Referenced by the price of 1 transaction in Table I.

F3

Represents the weighted average share price of an aggregate total of 13,161 shares sold in the price range of $2.205 to $2.38. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)